Clinical Trial Update: Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating intralesional ciprofloxacin injections for treating cutaneous leishmaniasis, in a comparator study against sodium stibogl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Ciprofloxacin intralesional injection (ciprofloxacin)
• Sodium stibogluconate (sodium stibogluconate)

Snippet

Sponsor: Al-Mustafa University College | Conditions: Cutaneous Leishmaniasis | Phase 2 | Status: RECRUITING